286 related articles for article (PubMed ID: 20008185)
1. Immune hemolytic anemia--selected topics.
Hoffman PC
Hematology Am Soc Hematol Educ Program; 2009; ():80-6. PubMed ID: 20008185
[TBL] [Abstract][Full Text] [Related]
2. Immune hemolytic anemia--selected topics.
Hoffman PC
Hematology Am Soc Hematol Educ Program; 2006; ():13-8. PubMed ID: 17124033
[TBL] [Abstract][Full Text] [Related]
3. [Autoimmune hemolytic anemia].
Karasawa M
Nihon Rinsho; 2008 Mar; 66(3):520-3. PubMed ID: 18326320
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Karlsson C; Hansson L; Celsing F; Lundin J
Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
[TBL] [Abstract][Full Text] [Related]
5. Clinical and serological characterization of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.
Yang Z; Wu B; Zhou Y; Wang W; Chen S; Sun A; Wu D; Xu Y
Chin Med J (Engl); 2014; 127(7):1235-8. PubMed ID: 24709172
[TBL] [Abstract][Full Text] [Related]
6. Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab.
Cheung WW; Hwang GY; Tse E; Kwong YL
Haematologica; 2006 May; 91(5 Suppl):ECR13. PubMed ID: 16709521
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune hemolytic anemia: diagnosis and management].
Philippe P
Presse Med; 2007 Dec; 36(12 Pt 3):1959-69. PubMed ID: 17481848
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia.
Park JA; Lee HH; Kwon HS; Baik CR; Song SA; Lee JN
Transfus Med Rev; 2016 Jan; 30(1):6-14. PubMed ID: 26481836
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and classification of autoimmune hemolytic anemia.
Bass GF; Tuscano ET; Tuscano JM
Autoimmun Rev; 2014; 13(4-5):560-4. PubMed ID: 24418298
[TBL] [Abstract][Full Text] [Related]
10. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C
Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
[TBL] [Abstract][Full Text] [Related]
11. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune haemolytic anemia: diagnosis strategy and new treatments].
Rigal D; Meyer F
Transfus Clin Biol; 2011 Apr; 18(2):277-85. PubMed ID: 21474357
[TBL] [Abstract][Full Text] [Related]
13. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.
Valent P; Lechner K
Wien Klin Wochenschr; 2008; 120(5-6):136-51. PubMed ID: 18365153
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation for Evans syndrome.
Oyama Y; Papadopoulos EB; Miranda M; Traynor AE; Burt RK
Bone Marrow Transplant; 2001 Nov; 28(9):903-5. PubMed ID: 11781654
[TBL] [Abstract][Full Text] [Related]
17. Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab.
Kako S; Kanda Y; Oshima K; Nishimoto N; Sato H; Watanabe T; Hosoya N; Motokura T; Miyakoshi S; Taniguchi S; Kamijo A; Takahashi K; Chiba S; Kurokawa M
Am J Hematol; 2008 Mar; 83(3):247-9. PubMed ID: 17918251
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.
Reynaud Q; Durieu I; Dutertre M; Ledochowski S; Durupt S; Michallet AS; Vital-Durand D; Lega JC
Autoimmun Rev; 2015 Apr; 14(4):304-13. PubMed ID: 25497766
[TBL] [Abstract][Full Text] [Related]
19. Current treatment strategies in autoimmune hemolytic disorders.
Barcellini W
Expert Rev Hematol; 2015 Oct; 8(5):681-91. PubMed ID: 26343892
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]